329 related articles for article (PubMed ID: 19458043)
1. Chromosomal instability determines taxane response.
Swanton C; Nicke B; Schuett M; Eklund AC; Ng C; Li Q; Hardcastle T; Lee A; Roy R; East P; Kschischo M; Endesfelder D; Wylie P; Kim SN; Chen JG; Howell M; Ried T; Habermann JK; Auer G; Brenton JD; Szallasi Z; Downward J
Proc Natl Acad Sci U S A; 2009 May; 106(21):8671-6. PubMed ID: 19458043
[TBL] [Abstract][Full Text] [Related]
2. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
Cai P; Lu P; Sharom FJ; Fang WS
Cancer Lett; 2013 Dec; 341(2):214-23. PubMed ID: 23941826
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability, colorectal cancer and taxane resistance.
Swanton C; Tomlinson I; Downward J
Cell Cycle; 2006 Apr; 5(8):818-23. PubMed ID: 16628000
[TBL] [Abstract][Full Text] [Related]
4. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability.
Raab M; Sanhaji M; Zhou S; Rödel F; El-Balat A; Becker S; Strebhardt K
Neoplasia; 2019 Apr; 21(4):363-375. PubMed ID: 30851646
[TBL] [Abstract][Full Text] [Related]
5. Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers.
Wang R; Wang H; Wang Z
J Vis Exp; 2017 Feb; (120):. PubMed ID: 28287508
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models.
Yee SS; Risinger AL
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279417
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor alpha (ESR1)-signaling regulates the expression of the taxane-response biomarker PRP4K.
Lahsaee S; Corkery DP; Anthes LE; Holly A; Dellaire G
Exp Cell Res; 2016 Jan; 340(1):125-31. PubMed ID: 26712520
[TBL] [Abstract][Full Text] [Related]
8. Taxane benefit in breast cancer--a role for grade and chromosomal stability.
A'Hern RP; Jamal-Hanjani M; Szász AM; Johnston SR; Reis-Filho JS; Roylance R; Swanton C
Nat Rev Clin Oncol; 2013 Jun; 10(6):357-64. PubMed ID: 23648828
[TBL] [Abstract][Full Text] [Related]
9. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Brooks TA; Minderman H; O'Loughlin KL; Pera P; Ojima I; Baer MR; Bernacki RJ
Mol Cancer Ther; 2003 Nov; 2(11):1195-205. PubMed ID: 14617793
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal instability confers intrinsic multidrug resistance.
Lee AJ; Endesfelder D; Rowan AJ; Walther A; Birkbak NJ; Futreal PA; Downward J; Szallasi Z; Tomlinson IP; Howell M; Kschischo M; Swanton C
Cancer Res; 2011 Mar; 71(5):1858-70. PubMed ID: 21363922
[TBL] [Abstract][Full Text] [Related]
11. A CERTain role for ceramide in taxane-induced cell death.
Kolesnick R; Altieri D; Fuks Z
Cancer Cell; 2007 Jun; 11(6):473-5. PubMed ID: 17560328
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
[TBL] [Abstract][Full Text] [Related]
13. Examining the link between chromosomal instability and aneuploidy in human cells.
Thompson SL; Compton DA
J Cell Biol; 2008 Feb; 180(4):665-72. PubMed ID: 18283116
[TBL] [Abstract][Full Text] [Related]
14. Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies.
Murray S; Briasoulis E; Linardou H; Bafaloukos D; Papadimitriou C
Cancer Treat Rev; 2012 Nov; 38(7):890-903. PubMed ID: 22465195
[TBL] [Abstract][Full Text] [Related]
15. Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.
Roque DM; Bellone S; Buza N; Romani C; Cocco E; Bignotti E; Ravaggi A; Rutherford TJ; Schwartz PE; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2013 Jul; 209(1):62.e1-9. PubMed ID: 23583215
[TBL] [Abstract][Full Text] [Related]
16. Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.
Matesanz R; Trigili C; Rodríguez-Salarichs J; Zanardi I; Pera B; Nogales A; Fang WS; Jímenez-Barbero J; Canales A; Barasoain I; Ojima I; Díaz JF
Bioorg Med Chem; 2014 Sep; 22(18):5078-90. PubMed ID: 25047938
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy.
McClelland SE; Burrell RA; Swanton C
Cell Cycle; 2009 Oct; 8(20):3262-6. PubMed ID: 19806022
[TBL] [Abstract][Full Text] [Related]
18. EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity.
Colbert PL; Vermeer DW; Wieking BG; Lee JH; Vermeer PD
Oncotarget; 2015 Jan; 6(2):953-68. PubMed ID: 25436983
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the structures of taxane derivatives and their microtubule polymerization activity.
Hidaka M; Koga T; Kiyota H; Horiguchi T; Shi QW; Hirose K; Uchida T
Biosci Biotechnol Biochem; 2012; 76(2):349-52. PubMed ID: 22313785
[TBL] [Abstract][Full Text] [Related]
20. Lx2-32c, a novel taxane derivative, exerts anti-resistance activity by initiating intrinsic apoptosis pathway in vitro and inhibits the growth of resistant tumor in vivo.
Zhou Q; Li Y; Jin J; Lang L; Zhu Z; Fang W; Chen X
Biol Pharm Bull; 2012; 35(12):2170-9. PubMed ID: 23207769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
